Literature DB >> 16026881

Autoregulated, bidirectional and multicistronic gas-inducible mammalian as well as lentiviral expression vectors.

Shizuka Hartenbach1, Martin Fussenegger.   

Abstract

We present a novel set of autoregulated, bidirectional and multicistronic mammalian as well as lentiviral expression vectors which enable transgene expression fine-tuning by gaseous acetaldehyde. The acetaldehyde-inducible regulation (AIR) technology capitalizes on Aspergillus nidulans components evolved to convert ethanol into metabolic energy. AIR is based on functional interaction of the fungal transactivator AlcR and AlcR-specific chimeric promoters (P(AIR)) which drive desired transgene expression in mammalian cells only in the presence of gaseous acetaldehyde. We have engineered AIR technology into a variety of different mammalian and lentiviral expression vector systems including (i) a most compact autoregulated expression format harboring alcR and the transgene in a single P(AIR)-driven transcription unit, (ii) a bidirectional P(AIR) derivative supporting expression of two transgenes with strict 1:1 transcription stoichiometry and (iii) a multicistronic expression arrangement providing simultaneous translation of three independent transgenes from a single P(AIR)-controlled transcript. All expression vectors have been validated in Chinese hamster ovary (CHO-K1), baby hamster kidney (BHK-21) and human HeLa cells for gas-inducible (co-)expression of the reporter transgenes such as Bacillus stearothermophilus-derived secreted alpha-amylase (SAMY), human vascular endothelial growth factor 121 (VEGF121), human placental-secreted alkaline phosphatase (SEAP) and Escherichia coli-derived chloramphenicol acetyl-transferase (CAT). The panoply of mammalian/lentiviral vectors presented here provides a robust and versatile expression platform for the first gas-inducible transgene control system which we expect to foster future advances in gene therapy, tissue engineering as well as biopharmaceutical manufacturing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026881     DOI: 10.1016/j.jbiotec.2005.03.025

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  6 in total

Review 1.  Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy.

Authors:  Ethlinn V B van Gaal; Wim E Hennink; Daan J A Crommelin; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

2.  Synthetic ecosystems based on airborne inter- and intrakingdom communication.

Authors:  Wilfried Weber; Marie Daoud-El Baba; Martin Fussenegger
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-05       Impact factor: 11.205

3.  Targeted genetic modification of cell lines for recombinant protein production.

Authors:  Niall Barron; Olga Piskareva; Mohan Muniyappa
Journal:  Cytotechnology       Date:  2007-02-28       Impact factor: 2.058

4.  Using cell engineering and omic tools for the improvement of cell culture processes.

Authors:  Darrin Kuystermans; Britta Krampe; Halina Swiderek; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2007-02-24       Impact factor: 2.058

5.  Efficient transduction of cytotoxic and anti-HIV-1 genes by a gene-regulatable lentiviral vector.

Authors:  Yasuhiko Shinoda; Kuniko Hieda; Yoshio Koyanagi; Youichi Suzuki
Journal:  Virus Genes       Date:  2009-10       Impact factor: 2.332

6.  Current status of transcriptional regulation systems.

Authors:  Tobias May; Hansjörg Hauser; Dagmar Wirth
Journal:  Cytotechnology       Date:  2006-05-20       Impact factor: 2.058

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.